Insider Transactions in Q2 2024 at Avidity Biosciences, Inc. (RNA)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
5,000
-25.21%
|
$185,000
$37.59 P/Share
|
|
Jun 20
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.14%
|
$5,000
$1.24 P/Share
|
|
Jun 18
2024
|
W. Michael Flanagan CSTO |
SELL
Open market or private sale
|
Direct |
10,106
-16.6%
|
$394,134
$39.13 P/Share
|
|
Jun 18
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
32,074
-18.37%
|
$1,250,886
$39.13 P/Share
|
|
Jun 18
2024
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,228
-16.25%
|
$437,892
$39.13 P/Share
|
|
Jun 18
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
9,864
-23.47%
|
$384,696
$39.13 P/Share
|
|
Jun 17
2024
|
W. Michael Flanagan CSTO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.96%
|
-
|
|
Jun 17
2024
|
Sarah Boyce President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+24.86%
|
-
|
|
Jun 17
2024
|
Michael F Mac Lean Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+24.87%
|
-
|
|
Jun 17
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+33.86%
|
-
|
|
Jun 14
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
35,767
-24.19%
|
$1,430,680
$40.08 P/Share
|
|
Jun 14
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,767
+19.48%
|
$35,767
$1.24 P/Share
|
|
Jun 13
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Indirect |
60,000
-28.05%
|
$2,400,000
$40.08 P/Share
|
|
Jun 13
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
164,233
-59.43%
|
$6,569,320
$40.08 P/Share
|
|
Jun 13
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
164,233
+37.28%
|
$164,233
$1.24 P/Share
|
|
Jun 12
2024
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
104,245
-70.28%
|
$3,648,575
$35.72 P/Share
|
|
Jun 12
2024
|
Michael F Mac Lean Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
104,245
+41.27%
|
$833,960
$8.82 P/Share
|
|
Jun 12
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Indirect |
40,000
-15.76%
|
$1,400,000
$35.07 P/Share
|
|
Jun 12
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
100,000
-47.14%
|
$3,500,000
$35.73 P/Share
|
|
Jun 12
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+32.04%
|
$100,000
$1.24 P/Share
|
|
Jun 04
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-19.98%
|
$756,000
$27.42 P/Share
|
|
Jun 04
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+16.66%
|
$28,000
$1.24 P/Share
|
|
May 20
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
5,000
-25.21%
|
$145,000
$29.9 P/Share
|
|
May 20
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.14%
|
$5,000
$1.24 P/Share
|
|
May 14
2024
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
75,000
-62.98%
|
$2,100,000
$28.28 P/Share
|
|
May 14
2024
|
Michael F Mac Lean Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+38.64%
|
$600,000
$8.82 P/Share
|
|
May 07
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-19.98%
|
$700,000
$25.54 P/Share
|
|
May 07
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+16.66%
|
$28,000
$1.24 P/Share
|
|
Apr 19
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
5,000
-25.21%
|
$110,000
$22.82 P/Share
|
|
Apr 19
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.14%
|
$5,000
$1.24 P/Share
|
|
Apr 03
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Indirect |
20,000
-7.3%
|
$540,000
$27.11 P/Share
|
|
Apr 02
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-19.98%
|
$728,000
$26.25 P/Share
|
|
Apr 02
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+16.66%
|
$28,000
$1.24 P/Share
|